Search results for "Quinuclidine"

showing 10 items of 16 documents

Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon

2004

Background and aims: Protease activated receptors (PARs) have been postulated to play a role during intestinal inflammation. The presence and role played by PAR4 in gastrointestinal functions have not been fully clarified. The aims of this study were: (i) to examine expression of PAR4 in rat proximal colon; (ii) to determine the mechanical effects induced by PAR4 activation in longitudinal muscle; and (iii) to characterise the underlying mechanisms. Methods: PAR4 expression was determined by reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry. Mechanical activity was recorded as changes in isometric tension. Results: A PCR product corresponding to the predicted…

AtropineMaleQuinuclidinesmedicine.medical_specialtyColonMotilityInflammationTetrodotoxinPROTEASE-ACTIVATED RECEPTORSBiologyIntestine InflammationSettore BIO/09 - Fisiologiachemistry.chemical_compoundNeurokinin-1 Receptor AntagonistsPiperidinesInternal medicinemedicineAnimalsRNA MessengerRats WistarReceptorSettore MED/12 - GastroenterologiaDose-Response Relationship DrugReverse Transcriptase Polymerase Chain ReactionGastroenterologyMuscle SmoothReceptors Neurokinin-2ColitisImmunohistochemistryRatsEndocrinologyMechanism of actionchemistryCapsaicinCROSS-REACTIVITYBenzamidesGASTRIC SMOOTH-MUSCLETetrodotoxinReceptors ThrombinCapsaicinmedicine.symptomGastrointestinal MotilityOligopeptidesAcetylcholineMuscle Contractionmedicine.drugMuscle contractionGut
researchProduct

Role of solvent and base in the silanization reaction of silicas for reversed-phase high-performance liquid chromatography

1984

Reversed-phase packings were synthesized by reaction of n-alkyldimethylchloro- and trifluoroacetoxysilanes with silicas of 15 and 25 nm pore size, employing tetrahydrofuran, N,N-dimethylformamide, benzene, diethyl ether, dichloromethane and acetonitrile as solvents and triethylamine, pyridine, triazole, quinuclidine, 2,4- and 2,6-lutidine and imidazole as bases. With dichloromethane as solvent and 2,6- lutidine as base, n-alkyldimethyltrifluoroacetoxysilanes did not yield n-alkyl ligand densities higher than those obtained with n-alkyldimethylchlorosilanes under identical conditions. With a given base and given n-alkyldimethylchlorosilane the solvent type was found to exert a noticeable inf…

ChromatographyOrganic ChemistryGeneral MedicineBiochemistryAnalytical ChemistrySolventchemistry.chemical_compoundchemistrySilanizationPyridineDiethyl etherAcetonitrileTetrahydrofuranQuinuclidineDichloromethaneJournal of Chromatography A
researchProduct

Altered tachykinergic influence on gastric mechanical activity in mdx mice

2006

Abstract This study investigated whether alterationsin gastric activity in dystrophic mdx mouse can beattributed to dysfunctions of tachykinins. Endolumi-nal pressure was recorded and the expression ofneuronal nitric oxide synthase (nNOS), NK1 and NK2neurokinin receptors was investigated by immunoh-istochemistry. SR48968, NK2 receptor antagonist, butnot SR140333, NK1 receptor antagonist, decreased thetone only in mdx gastric preparations. In the presenceof N x -nitro- L -arginine methyl ester ( L -NAME), inhib-itor of NOS, SR48968 reduced the tone also in normalstomach. [Sar 9 , Met(O 2 ) 11 ]-SP, agonist of NK1 recep-tors, caused tetrodotoxin-sensitive relaxations, antag-onized by SR140333…

MaleAgonistQuinuclidinesmedicine.medical_specialtymdx mouseManometryPhysiologymedicine.drug_classNitric Oxide Synthase Type ISettore BIO/09 - FisiologiaNitric oxideMicechemistry.chemical_compoundimmunohistochemistry mdx mouse nitric oxide stomach tachykininsOrgan Culture TechniquesNeurokinin-1 Receptor AntagonistsPiperidinesTachykininsInternal medicinemedicineAnimalsEnzyme InhibitorsReceptorbiologyEndocrine and Autonomic SystemsStomachStomachGastroenterologyAntagonistMuscle SmoothReceptors Neurokinin-2Receptors Neurokinin-1musculoskeletal systemImmunohistochemistryMuscular Dystrophy DuchenneNitric oxide synthaseDisease Models AnimalNG-Nitroarginine Methyl Estermedicine.anatomical_structureEndocrinologychemistryMuscle TonusBenzamidesMice Inbred mdxbiology.proteinNK1 receptor antagonistGastrointestinal MotilityMuscle Contraction
researchProduct

One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients

2019

Purpose: Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared and disturbing adverse events of cancer treatment associated with decreased adherence to effective chemotherapy regimens. For high-risk soft tissue sarcoma patients, receiving multiple-day chemotherapy (MD-CT), antiemetic guidelines recommend a combination of an NK 1 receptor antagonist (NK 1 -RA), a 5-HT 3 receptor antagonist (5HT 3 -RA), and dexamethasone on each day of the antineoplastic treatment. NEPA is the first oral fixed-dose combination of a highly selective NK 1 -RA, netupitant, and second-generation 5HT 3 -RA, palonosetron. So far, no data has been published in literature about the efficacy of a s…

MaleOncologyQuinuclidinesMultiple-dayPyridinesmedicine.medical_treatmentCINVPilot ProjectsDexamethasonechemistry.chemical_compound0302 clinical medicineNeurokinin-1 Receptor AntagonistsClinical endpointSerotonin 5-HT3 Receptor AntagonistsProspective Studies030212 general & internal medicineAged 80 and overSoft tissue sarcomaPalonosetronNauseaSarcomaMiddle AgedReceptors Neurokinin-1PalonosetronOncology030220 oncology & carcinogenesisVomitingFemaleOriginal Articlemedicine.symptommedicine.drugAdultmedicine.medical_specialtyVomitingmedicine.drug_classNauseaAntineoplastic Agents03 medical and health sciencesInternal medicinemedicineHumansAntiemeticNetupitantAuthor CorrectionAgedChemotherapybusiness.industryIsoquinolinesmedicine.diseasechemistryNetupitantAntiemeticsbusinessSupportive Care in Cancer
researchProduct

Single-dose Palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving mode…

2011

PURPOSE: The control of nausea and vomiting induced by chemotherapy is paramount for overall treatment success in cancer patients. Antiemetic therapy during chemotherapy in lymphoma patients generally consists of anti-serotoninergic drugs and dexamethasone. The aim of this trial was to evaluate the efficacy of a single dose of palonosetron, a second-generation serotonin type 3 (5-HT(3)) receptor antagonist, in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy (MEC) containing steroids. METHODS: Patients received a single intravenous bolus of palonosetron (0.25 mg) before administration of chemotherapy. Complete response (CR) defined as no vomiting …

MaleQuinuclidinesmedicine.medical_treatmentCINVCHOPGastroenterologyDexamethasoneSettore MED/15 - Malattie Del SangueAntineoplastic Combined Chemotherapy ProtocolsSerotonin 5-HT3 Receptor AntagonistsProspective StudiesAged 80 and overLymphoma Non-HodgkinPalonosetronNauseaMiddle AgedEmesisPalonosetronTreatment OutcomeOncologyAnesthesiaCHOP CINV Emesis Nausea NHL PalonosetronVomitingFemaleOriginal Articlemedicine.symptomCHOP-CINV; emesis; nausea; NHL; Palonosetronmedicine.drugAdultmedicine.medical_specialtyVomitingNauseamedicine.drug_classNHLYoung AdultInternal medicinemedicineHumansAntiemeticGlucocorticoidsAgedChemotherapybusiness.industryIsoquinolinesmedicine.diseaseNon-Hodgkin's lymphomaAntiemeticsbusinessCHOPChemotherapy-induced nausea and vomiting
researchProduct

A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Resu…

2005

Abstract Objective: To compare two new generation antimuscarinics at their recommended doses for treatment of overactive bladder syndrome (OAB). Methods: A prospective, double blind, double-dummy, two-arm, parallel-group, 12-week study was conducted to compare the efficacy and safety of solifenacin 5 or 10mg and tolterodine extended release (ER) 4mg once daily in OAB patients. After 4 weeks of treatment patients had the option to request a dose increase but were dummied throughout as approved product labelling only allowed an increase for those on solifenacin. Results: Solifenacin, with a flexible dosing regimen, showed greater efficacy to tolterodine in decreasing urgency episodes, inconti…

MaleSolifenacin SuccinateQuinuclidinesmedicine.medical_specialtyUrinary urgencyTolterodine TartrateUrologyPhenylpropanolamineUrologyMuscarinic AntagonistsTolterodine TartrateCresolsDouble-Blind MethodTetrahydroisoquinolinesmedicineHumansProspective StudiesBenzhydryl CompoundsAnalysis of VarianceSolifenacinbusiness.industrySolifenacin SuccinateMiddle Agedmedicine.diseaseRegimenTreatment OutcomeUrinary IncontinenceTolerabilityOveractive bladderFemaleTolterodinemedicine.symptombusinessmedicine.drugEuropean Urology
researchProduct

Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands

2001

In our search for M2-selective muscarinic receptor antagonists, we synthesized 1,3-disubstituted indenes. The effects of different basic moieties with regard to binding and selectivity towards the five distinct muscarinic receptor subtypes were investigated. The results show that the quinuclidine series afforded the most promising compounds in terms of both receptor affinity and M2-subtype selectivity.

QuinuclidinesTertiary amineStereochemistryClinical BiochemistryPharmaceutical ScienceIn Vitro TechniquesLigandsBiochemistryChemical synthesischemistry.chemical_compoundAlzheimer DiseaseDrug DiscoveryMuscarinic acetylcholine receptorHumansReceptorMolecular BiologyAcetylcholine receptorReceptor Muscarinic M2Bicyclic moleculeOrganic ChemistryReceptors MuscarinicchemistryMolecular MedicineRadiopharmaceuticalsSelectivityTomography Emission-ComputedQuinuclidineBioorganic & Medicinal Chemistry Letters
researchProduct

Molecular aggregates of quinuclidine and chlorophyll a

1991

A slightly polar molecule quinuclidine seems to form weakly bound aggregates in concentrated water solutions. Molecular dynamics simulation of a 6 mol water solution indicates clustering of quinuclidine molecules into an almost spherical structure with polar ends of the molecules pointing towards the solvent. Experimental evidence of aggregation was obtained by observing a small but obvious red shift of the o'' a absorption and a dramatic shortening of the fluorescence lifetime of the c n transition of concentrated solutions. The observed self-quenching is interpreted in terms of Frster model for energy transfer in the cluster. It is estimated that excitation may migrate on the cluster surf…

Solventchemistry.chemical_compoundMolecular dynamicsMonomerChemistryChemical polarityMoleculeAbsorption (chemistry)PhotochemistryLuminescenceQuinuclidineSPIE Proceedings
researchProduct

CCDC 2079430: Experimental Crystal Structure Determination

2021

Related Article: Jas S. Ward, Antonio Frontera, Kari Rissanen|2021|Dalton Trans.|50|8297|doi:10.1039/D1DT01437D

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersbis(quinuclidine)iodonium hexafluorophosphateExperimental 3D Coordinates
researchProduct

CCDC 2079431: Experimental Crystal Structure Determination

2021

Related Article: Jas S. Ward, Antonio Frontera, Kari Rissanen|2021|Dalton Trans.|50|8297|doi:10.1039/D1DT01437D

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersbis(quinuclidine)iodonium nitrateExperimental 3D Coordinates
researchProduct